Life Sciences & Deep Tech

Make complex value easier to understand.

Scientific depth should create credibility, not friction.

The WeKwikGene platform homepage
WeKwikGene — a scientific platform a researcher can navigate without being sold to. Read the case
Recurring tensions

What tends to break.

The same brief fails in a different place at every stage of proof.

The evidence ladder — and what each rung changes about the work

  • In-vitroProof exists in a dish. The work has to signal rigour without implying a patient outcome, and without burying the method.
  • In-vivoProof exists in an organism. Diagrams and data take over from adjectives, and regulatory wording starts to constrain every claim.
  • ClinicalProof exists in people. Trust moves to governance, trial design and the standing of whoever is behind the result.
  • CommercialProof has to survive a procurement review. The site now has to answer risk, support and integration before anyone will speak to sales.

The translation table

AssayWhat the buyer hears: can this be measured?
SensitivityWhat the buyer hears: will it miss something important?
ProtocolWhat the buyer hears: how much work is this for my team?
ValidationWhat the buyer hears: has anyone independent checked this?

Where it breaks: a page that leads with scientific vocabulary loses the buyer, a page that leads with outcomes loses the scientist — and both of them sit on the same committee.

Buyer reality

The people choosing you are solving their own problem.

Sector expertise matters because different buyers need different proof, language and confidence before they act.

01

Researchers / technical users

Need precision, usability and enough detail to trust the system.

02

Business buyers

Need the commercial relevance translated without feeling that the science has been diluted.

03

Investors / partners

Need a clear narrative connecting technical advantage to strategic value.

What we usually prioritize

The levers change by category.

Life-science brands often need to communicate with multiple audiences without creating separate identities for each one.

ClarityMake technical value legible.
TrustPreserve rigor and evidence.
DistinctionAvoid generic institutional aesthetics.
TranslationBridge scientific and commercial audiences.
One relevant project

Where this shows up: Life sciences & deep tech.

One real project from this category, and the decision model we use in it.

01

Complexity

What the science actually proves
02

Structure

The information architecture a buyer can follow
03

Proof

Published work, methods and people
04

Adoption

The path from reading to buying
WeKwikGene homepage
WeKwikGene — a research platform repositioned from a tool into a service. Read the case study ↗
WeKwikGene research catalogue
WeKwikGene — the catalogue a scientist actually has to navigate.

Next step

Sector knowledge helps us ask better questions.

  • It does not replace research. Every engagement still starts with the specific business, market and customer journey.